@ARTICLE{
author={Spigel David R,...,Chen Yuanbin,Navarro Alejandro,Chih Hsin Yang James,Stojanovic Goran,Jove Maria,...,Andric Zoran G,...,(broj koautora 17)},
year={2025},
title={Reply to P. de Boissieu et al},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={43},
number={3},
pages={-},
document_type={Letter},
} 

@ARTICLE{
author={Spigel David R,...,Stojanovic Goran,...,Andric Zoran G,...,(broj koautora 17)},
year={2024},
title={RESILIENT Part 2: A Randomized, Open-Label Phase III Study of Liposomal Irinotecan Versus Topotecan in Adults With Relapsed Small Cell Lung Cancer},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={42},
number={19},
pages={-},
document_type={Article},
} 

@ARTICLE{
author={Spigel David R,...,Andric Zoran G,...,(broj koautora 20)},
year={2019},
title={IMpower110: Interim overall survival (OS) analysis of a phase III study of atezolizumab (atezo) vs platinum-based chemotherapy (chemo) as first-line (1L) treatment (tx) in PD-L1-selected NSCLC},
journal={ANNALS OF ONCOLOGY},
volume={30},
number={},
pages={915-915},
document_type={Meeting Abstract},
}